Global Gastrointestinal / GI Stent Market – Size, Outlook, Trends and Forecast (2024 – 2032)

A gastrointestinal stent is primarily used as a safe and effective alternative to surgery or repetitive endoscopic procedures to widen a narrow or stenosed lumen in order to maintain the patency of the lumen. Global gastrointestinal / GI stent market was valued at $0.36 billion and expected to $0.47 billion by 2025 with a CAGR of XX% during the forecast period 2019-2025. The factors like rising prevalence of gastrointestinal cancers and other digestive diseases and growing preference for minimally invasive procedures are driving the market growth. The factors like complication and delay in diagnosis associated with gastrointestinal stent implementation and delays in diagnosis with gastrointestinal stent implementation are hampering the market growth. Development of biodegradable and drug-eluting gastrointestinal stents are creating the opportunities for market growth.

Research Study Objectives:

• Define, estimate, and forecast the Gastrointestinal / GI Stent market statistics by product, material, diseases type, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Gastrointestinal / GI Stent market growth
• Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
• Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
• Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Gastrointestinal / GI Stent Market Analysis
• Analysis and conclusions on the future Gastrointestinal / GI Stent market outlook.

Top-down and bottom-up approaches are used to validate the Gastrointestinal / GI Stent Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Gastrointestinal / GI Stent Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Gastrointestinal / GI Stent market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The Gastrointestinal / GI Stent market segmentation is as follows:

By Product

• Colonic Stents
• Duodenal Stents
• Pancreatic Stents
• Oesophagal Stents
• Biliary Stents
• Others

By Material

• Plastic Stents
• Self-Expanding Metal Stents
• Stainless Steel Stents
• Nitinol Stents
• Others

By Diseases Type

• Inflammatory Bowel Diseases
• Biliary Diseases
• Gastrointestinal Cancer
• Pancreatic Cancer
• Oesophagal Cancer
• Colorectal Cancer
• Stomach Cancer

By End User

• Ambulatory Surgery Centers
• Hospitals
• Others

Geographical Analysis:

Gastrointestinal / GI Stent Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Gastrointestinal / GI Stent Market include:

• Scope Revision
• Geographic Analysis
• Company Profiles
• Historical Data & Forecasting
• Key Contact Persons in companies

Global Gastrointestinal / GI Stent Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact on altering market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the significant Gastrointestinal / GI Stent market players, such as
  • Olympus Corporation
  • Becton, Dickinson and Company
  • Taewoong Medical Co., Ltd.
  • Boston Scientific Corporation
  • Merit Medical Systems, Inc.
• Along with these companies, many other companies are considered in the report while analysing the Global Gastrointestinal / GI Stent competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.